-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Effectiveness and safety of HPV Vaccine From: Kim E. Goldman (goldman@calweb.com) Sun Jun 11 00:38:44 2006 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Dr Eberhard Lisse: "Re: actinomyces & pregnancy" Previous message: Kim E. Goldman: "Re: HPV Vaccine" In reply to: RModugno@aol.com: "Effectiveness and safety of HPV Vaccine" So how long has the vaccine been studied? Sounds like a maximum of 4 years. And it is protective against vaginal and vulvar cancer for only two years? Hmmm I'd like to know more. Not a very long track record for something that is going to be given to young girls. As you stated in your previous post, the concern here is not that giving such a vaccine would be considered permissive but rather whether long term it is safe and effective. Kim On Jun 10, 2006, at 7:19 PM, RModugno@aol.com wrote: > From WebMD: > > Effective and Safe > > In clinical trials reported so far, the vaccine has been extremely > effective. It appears to be 100% effective in protecting against > the HPV-16 and HPV-18 strains. It also seems extremely safe. One > reason is that the vaccine isn't a live virus, but a virus-like > particle. This means it's an empty shell, with immunity-stimulating > particles on the outside and no viral machinery on the inside. > > HPV expert Jessica Kahn MD, MPH, associate professor of pediatrics > at Cincinnati Children's Hospital Medical Center, says she's > planning to have her teenage daughter vaccinated. > > "What we parents most want to know about the vaccine is whether it > is safe, and whether it is effective," Kahn tells WebMD. "All data > show it to be one of the safest vaccines ever tested. And it is > highly effective." > > To be effective, Gardasil must be given in three doses over six > months (the second dose is given two months after the first; the > third dose six months after the first). It's not yet clear whether > a person will receive lifelong immunity. In tests checking for > presence of the virus so far, the vaccines remain protective for > four years and counting. For preventing vaginal and vulvar cancer, > the vaccines have been protective for at least two years. > > ************************************************************* > > Robert Modugno MD MBA FACOG > > Marietta, GA Next message: Dr Eberhard Lisse: "Re: actinomyces & pregnancy" Previous message: Kim E. Goldman: "Re: HPV Vaccine" In reply to: RModugno@aol.com: "Effectiveness and safety of HPV Vaccine"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Sun Nov 2 04:56:10 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.